查找临床试验
已按「视神经脊髓炎」检索，对应国际通用词 neuromyelitis optica
共找到 48 项正在招募的试验
数据更新于 00:19，每 5 分钟自动同步正在招募不适用NCT07202494
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
France
年龄 18 Years – 90 Years
Assistance Publique Hopitaux De Marseille
正在招募不适用NCT06780709
Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
United States
年龄 18 Years – 不限
Icahn School of Medicine at Mount Sinai
正在招募早期 I 期中国有中心NCT05145361
Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
China
年龄 18 Years – 不限
Shanghai Pharmaceuticals Holding Co., Ltd
正在招募II 期 / III 期中国有中心NCT06413654
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
China
年龄 18 Years – 不限
Shanghai Jiaolian Drug Research and Development Co., Ltd
正在招募IV 期中国有中心NCT07410039
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
China
年龄 18 Years – 65 Years
Chinese PLA General Hospital
正在招募I 期 / II 期中国有中心NCT05504694
Ofatumumab in AQP4-IgG Seropositive NMOSD
China
年龄 18 Years – 不限
Tang-Du Hospital
正在招募I 期NCT07085676
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Israel
年龄 18 Years – 80 Years
Polina Stepensky
正在招募不适用中国有中心NCT04106830
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
China
年龄 16 Years – 75 Years
Beijing Tiantan Hospital
正在招募I 期 / II 期NCT07738952
Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder
Japan
年龄 18 Years – 不限
Kyushu University
正在招募不适用中国有中心NCT06829524
HANDLE-a Real World Study on Satralizumab in NMOSD
China
年龄 12 Years – 不限
Huashan Hospital
正在招募III 期中国有中心NCT07557420
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
China
年龄 18 Years – 130 Years
Alexion Pharmaceuticals, Inc.
正在招募不适用NCT06312644
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
United States、Australia、France、Germany、Italy 等 7 国
年龄 不限 – 不限
Alexion Pharmaceuticals, Inc.